Cargando…
WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis
Epithelioid hemangioendothelioma (EHE) is a genetically homogenous vascular sarcoma that is a paradigm for TAZ dysregulation in cancer. EHE harbors a WWTR1(TAZ)-CAMTA1 gene fusion in >90% of cases, 45% of which have no other genetic alterations. In this study, we used a first of its kind approach...
Autores principales: | Seavey, Caleb N., Pobbati, Ajaybabu V., Hallett, Andrea, Ma, Shuang, Reynolds, Jordan P., Kanai, Ryan, Lamar, John M., Rubin, Brian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015722/ https://www.ncbi.nlm.nih.gov/pubmed/33766982 http://dx.doi.org/10.1101/gad.348220.120 |
Ejemplares similares
-
Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ–CAMTA1 Fusion Driven Sarcoma
por: Seavey, Caleb N., et al.
Publicado: (2022) -
The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras–MAPK Signaling in Epithelioid Hemangioendothelioma
por: Ma, Shuang, et al.
Publicado: (2022) -
WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma
por: Driskill, Jordan H., et al.
Publicado: (2021) -
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020) -
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)